NOVARTIS GENE THERAPIES EU LIMITED
Closed at May 17th, 2025
Keywords
stenographystenotypingtranscriptioncourt stenographysimultaneous captioningaddress bar codingbar code printingfundraisingforfeiture servicesloyalty programs
Organization
- CEO
- SR
Sissel Rodahl1966
- Operation time
- 5 years
- - Apr 16, 2020 to May 17, 2025
- Type
- Norwegian division of foreign business enterprise
- VAT registered
- No
- Number of employees
- 0
Last update: Aug 29, 2024
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
SR 1966 | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
| Information about the Company in the Home Country | - |
Last update: Oct 6, 2023
Ownership
No available data
Financials
in NOK
No available data
Classification
Category
Type of organization
Norwegian division of foreign business enterprise
Standard industrial classification
N
Main industrial area
Administrative and support service activities
82
Activity
Office administrative, office support and other business support activities
82.9
Main industrial group
Business support service activities n.e.c.
82.99
Industrial group
Other business service activities n.e.c.
82.990
Industrial group
Other business service activities n.e.c.